Search hospitals > Colorado > Colorado Springs
Penrose-Saint Francis Healthcare
Claim this profileColorado Springs, Colorado 80907
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
316 reported clinical trials
3 medical researchers
Summary
Penrose-Saint Francis Healthcare is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Penrose-Saint Francis Healthcare is involved with conducting 316 clinical trials across 475 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
172 reported clinical trials
239 drugs studied
Shahzad SiddiquePenrose-Saint Francis Healthcare4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
111 reported clinical trials
176 drugs studied
Mehmet S. CopurBethesda North Hospital12 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
2 reported clinical trials
8 drugs studied
Clinical Trials running at Penrose-Saint Francis Healthcare
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Gastric Cancer
Pancreatic Cancer
Multiple Myeloma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Penrose-Saint Francis Healthcare?
Penrose-Saint Francis Healthcare is a medical facility located in Colorado Springs, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Penrose-Saint Francis Healthcare is involved with conducting 316 clinical trials across 475 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Where is Penrose-Saint Francis Healthcare located?
Penrose-Saint Francis Healthcare is located at 2222 N Nevada Ave, Colorado Springs, CO 80907, near the intersection of Circle Drive and Union Boulevard. It is directly across from the Audubon Medical Campus and Medical Center Point.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Penrose-Saint Francis Healthcare, contact the Financial Counseling department at 719-776-7489. For billing or payment inquiries, call the customer service line at 303-381-1549. Additionally, for further assistance with billing and financial services, email Centura Health at ptaccessbillingissues@centura.org or call 303-486-5400 or 800-953-0104.
What insurance does Penrose-Saint Francis Healthcare accept?
Penrose-Saint Francis Healthcare, part of the Centura Health system, accepts various insurance plans, including Medicare and Medicaid, and welcomes most major insurances. For a detailed list of accepted insurance plans, contacting the hospital directly or visiting their official website is recommended. Insurance networks are subject to change, so confirming coverage with your provider for specific procedures and facilities is advised.
What awards or recognition has Penrose-Saint Francis Healthcare received?
Penrose-Saint Francis Healthcare, located in Colorado Springs, Colorado, has been recognized as one of America's 50 best hospitals by Healthgrades in 2017 and one of America's 250 best hospitals in 2022. It is a part of CommonSpirit Health, dedicated to delivering high-quality healthcare services to the community.